Skip to main content
SpringerLink
Log in

Diabetic Neuropathy

  • Chapter
  • First Online:
Limb Salvage of the Diabetic Foot

Abstract

Diabetic neuropathy (DN) is one of the most common complications related to diabetes. While any nerve in the body may be affected, the length dependent distal symmetrical sensory predominant neuropathy (DSPN) is the most classical presentation. DSPN develops insidiously and often remains asymptomatic until well established. Important complications of DSPN include the development of neuropathic pain, foot deformities and ulceration all which lead to considerable morbidity and which may put the patient on a pathway to lower extremity amputation. Impairment of autonomic control may lead to various presentations from the organ systems involved such as cardiovascular, gastrointestinal, genitourinary and sudomotor neuropathies. Although hyperglycaemia related neuronal damage has been long considered the key aetiopathogenic trigger, more recently other factors, such as cardiometabolic and vascular risk factors, are increasingly recognised to play a significant role in DN development. Newer putative agents, although have shown promise in experimental diabetic neuropathy, are yet to be proven clinically. Thus, glucose control remains the only proven strategy to delay the development of DN. Treatment of neuropathic pain, an annual foot risk assessment and ulcer prevention strategies along with symptomatic management of autonomic features and optimisation of cardiovascular risk factors are important management considerations. In this review, we discuss the classification, diagnosis and management of the DN with a focus on DSPN.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7million participants. Lancet. 2011;378:31–40.

    Article  CAS  PubMed  Google Scholar 

  2. Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care. 2003;26:1895–901.

    Article  PubMed  Google Scholar 

  3. Hsu WC, Chiu SYH, Yen AMF, Chen LS, Fann CY, Liao CS, et al. Somatic neuropathy is an independent predictor of all- and diabetes-related mortality in type 2 diabetic patients: a population-based 5-year follow-up study (KCIS No. 29). Eur J Neurol. 2012;19:1192–8.

    Article  PubMed  Google Scholar 

  4. Vas PR, Edmonds ME. Early recognition of diabetic peripheral neuropathy and the need for one-stop microvascular assessment. Lancet Diabetes Endocrinol. 2016;4(9):723–5. https://doi.org/10.1016/S2213-8587(16)30063-8.

    Article  PubMed  Google Scholar 

  5. Vileikyte L, Gonzalez JS. Recognition and management of psychosocial issues in diabetic neuropathy. Handb Clin Neurol. 2014;126:195–209.

    Article  PubMed  Google Scholar 

  6. Hex N, Bartlett C, Wright D, Taylor M, Varley D. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med. 2012;29:855–62.

    Article  CAS  PubMed  Google Scholar 

  7. Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care. 2003;26:1790–5.

    Article  PubMed  Google Scholar 

  8. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28:956–62.

    Article  PubMed  Google Scholar 

  9. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33:2285–93.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Thomas PK. Classification, differential diagnosis, and staging of diabetic peripheral neuropathy. Diabetes. 1997;46(Suppl 2):S54–7.

    Article  CAS  PubMed  Google Scholar 

  11. Pop-Busui R, Boulton AJM, Feldman EL, Bril V, Freeman R, Malik RA, et al. Diabetic neuropathy: a position statement by the american diabetes association. Diabetes Care. 2017;40:136–54.

    Article  CAS  PubMed  Google Scholar 

  12. Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, Ionescu-Tirgoviste C, et al. Vascular risk factors and diabetic neuropathy. N Engl J Med. 2005;352:341–50.

    Article  CAS  PubMed  Google Scholar 

  13. Dyck P, Kratz K, Karnes J, Litchy W, Klein R, Pach J, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort the Rochester diabetic neuropathy study. Neurology. 1993;43:817.

    Article  CAS  PubMed  Google Scholar 

  14. Martin CL, Albers JW, Pop-Busui R. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care. 2014;37:31–8.

    Article  CAS  PubMed  Google Scholar 

  15. Maser RE, Steenkiste AR, Dorman JS, Nielsen VK, Bass EB, Manjoo Q, et al. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh epidemiology of diabetes complications study. Diabetes. 1989;38:1456–61.

    Article  CAS  PubMed  Google Scholar 

  16. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, Hann AW, Hussein A, et al. The north-west diabetes foot care study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002;19:377–84.

    Article  CAS  PubMed  Google Scholar 

  17. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36:150–4.

    Article  CAS  PubMed  Google Scholar 

  18. Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu-Tirgoviste C, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia. 1996;39:1377–84.

    Article  CAS  PubMed  Google Scholar 

  19. Veves A, Backonja M, Malik RA. Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med. 2008;9:660–74.

    Article  PubMed  Google Scholar 

  20. Abbott CA, Malik RA, van Ross ER, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care. 2011;34:2220–4.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006;29:1518–22.

    Article  PubMed  Google Scholar 

  22. Daousi C, MacFarlane IA, Woodward A, Nurmikko TJ, Bundred PE, Benbow SJ. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med. 2004;21:976–82.

    Article  CAS  PubMed  Google Scholar 

  23. Kim SS, Won JC, Kwon HS, Kim CH, Lee JH, Park TS, et al. Prevalence and clinical implications of painful diabetic peripheral neuropathy in type 2 diabetes: results from a nationwide hospital-based study of diabetic neuropathy in Korea. Diabetes Res Clin Pract. 2014;103:522–9.

    Article  PubMed  Google Scholar 

  24. Novella SP, Inzucchi SE, Goldstein JM. The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve. 2001;24:1229–31.

    Article  CAS  PubMed  Google Scholar 

  25. Singleton JR, Smith AG, Russell JW, Feldman EL. Microvascular complications of impaired glucose tolerance. Diabetes. 2003;52:2867–73.

    Article  CAS  PubMed  Google Scholar 

  26. Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A. Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg surveys S2 and S3. Pain Med. 2009;10:393–400.

    Article  PubMed  Google Scholar 

  27. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–53.

    Google Scholar 

  28. Siegelaar SE, Kilpatrick ES, Rigby AS, Atkin SL, Hoekstra JB, DeVries JH. Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT. Diabetologia. 2009;52:2229–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Franklin GM, Shetterly SM, Cohen JA, Baxter J, Hamman RF. Risk factors for distal symmetric neuropathy in NIDDM. The San Luis Valley Diabetes Study. Diabetes Care. 1994;17:1172–7.

    Article  CAS  PubMed  Google Scholar 

  30. Dyck PJ, Litchy WJ, Lehman KA, Hokanson JL, Low PA, O’Brien PC. Variables influencing neuropathic endpoints. The Rochester diabetic neuropathy study of healthy subjects. Neurology. 1995;45:1115–21.

    Article  CAS  PubMed  Google Scholar 

  31. Stratton IM, Holman RR, Boulton AJM. Risk factors for neuropathy in UKPDS. Diabetologia. 2004;47(Suppl 1):A47.

    Google Scholar 

  32. Perkins BA, Orszag A, Ngo M, Ng E, New P, Bril V. Prediction of incident diabetic neuropathy using the monofilament examination: a 4-year prospective study. Diabetes Care. 2010;33:1549–54.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Paisey RB, Darby T, George AM, Waterson M, Hewson P, Paisey CF, Thomson MP. Prediction of protective sensory loss, neuropathy and foot ulceration in type 2 diabetes. BMJ Open Diabetes Res Care. 2016;4(1):e000163.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Tesfaye S, Selvarajah D. The Eurodiab study: what has this taught us about diabetic peripheral neuropathy? Curr Diab Rep. 2009;9:432–4.

    Article  PubMed  Google Scholar 

  35. Wiggin TD, Sullivan KA, Pop-Busui R, Amato A, Sima AA, Feldman EL. Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes. 2009;58:1634–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Vas PR, Sharma S, Rayman G. LDIflare small fiber function in normal glucose tolerant subjects with and without hypertriglyceridemia. Muscle Nerve. 2015;52:113–9.

    Article  CAS  PubMed  Google Scholar 

  37. Vincent AM, Hinder LM, Pop-Busui R, Feldman EL. Hyperlipidemia: a new therapeutic target for diabetic neuropathy. J Peripher Nerv Syst. 2009;14:257–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Nilsen KB, Nicholas AK, Woods CG, Mellgren SI, Nebuchennykh M, Aasly J. Two novel SCN9A mutations causing insensitivity to pain. Pain. 2009;143:155–8.

    Article  CAS  PubMed  Google Scholar 

  39. Ahlqvist E, van Zuydam NR, Groop LC, McCarthy MI. The genetics of diabetic complications. Nat Rev Nephrol. 2015;11:277–87.

    Article  CAS  PubMed  Google Scholar 

  40. Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012;11:521–34.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Vincent AM, Callaghan BC, Smith AL, Feldman EL. Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat Rev Neurol. 2011;7:573–83.

    Article  CAS  PubMed  Google Scholar 

  42. Pasnoor M, Dimachkie MM, Kluding P, Barohn RJ. Diabetic neuropathy part 1: overview and symmetric phenotypes. Neurol Clin. 2013;31:425–45.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Smith AG, Singleton JR. Idiopathic neuropathy, prediabetes and the metabolic syndrome. J Neurol Sci. 2006;242:9–14.

    Article  Google Scholar 

  44. Breiner A, Lovblom LE, Perkins BA, Bril V. Does the prevailing hypothesis that small-fiber dysfunction precedes large-fiber dysfunction apply to type 1 diabetic patients? Diabetes Care. 2014;37:1418–24.

    Article  PubMed  Google Scholar 

  45. Ziegler D, Papanas N, Zhivov A, Allgeier S, Winter K, Ziegler I, et al. Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes. Diabetes. 2014;63:2454–63.

    Article  PubMed  Google Scholar 

  46. Papanas N, Ziegler D. Polyneuropathy in impaired glucose tolerance: is postprandial hyperglycemia the main culprit? A mini-review. Gerontology. 2013;59:193–8.

    Article  CAS  PubMed  Google Scholar 

  47. Boulton AJ. Diabetic neuropathy: classification, measurement and treatment. Curr Opin Endocrinol Diabetes Obes. 2007;14:141–5.

    Article  PubMed  Google Scholar 

  48. Petrova NL, Moniz C, Elias DA, Buxton-Thomas M, Bates M, Edmonds ME. Is there a systemic inflammatory response in the acute charcot foot? Diabetes Care. 2007;30:997–8.

    Article  PubMed  Google Scholar 

  49. Boulton AJ, Kirsner RS, Vileikyte L. Neuropathic diabetic foot ulcers. New England J Med. 2004;351:48–55.

    Article  CAS  Google Scholar 

  50. Søfteland E, Brock C, Frøkjær JB, Brøgger J, Madácsy L, Gilja OH, et al. Association between visceral, cardiac and sensorimotor polyneuropathies in diabetes mellitus. J Diab Complicat. 2014;28:370–7.

    Article  Google Scholar 

  51. Alleman CJ, Westerhout KY, Hensen M, Chambers C, Stoker M, Long S, et al. Humanistic and economic burden of painful diabetic peripheral neuropathy in Europe: a review of the literature. Diabetes Res Clin. 2015;109(2):215–25. https://doi.org/10.1016/j.diabres.2015.04.031.

    Article  Google Scholar 

  52. Selvarajah D, Cash T, Sankar A, Thomas L, Davies J, Cachia E, et al. The contributors of emotional distress in painful diabetic neuropathy. Diab Vasc Dis Res. 2014;11:218–25.

    Article  PubMed  Google Scholar 

  53. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26:1553–79.

    Article  PubMed  Google Scholar 

  54. Spallone V, Bellavere F, Scionti L, Maule S, Quadri R, Bax G, et al. Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy. Nutr Metab Cardiovasc Dis. 2011;21:69–78.

    Article  CAS  PubMed  Google Scholar 

  55. Camilleri M. Diabetic gastroparesis. N Engl J Med. 2007;356:820–9.

    Article  CAS  PubMed  Google Scholar 

  56. Malik RA. Why are there no good treatments for diabetic neuropathy? Lancet Diab Endocrinol. 2014;2:607–9.

    Article  Google Scholar 

  57. Vas PR, Sharma S, Rayman G. Distal sensorimotor neuropathy: improvements in diagnosis. Rev Diabet Stud. 2015;12:29–47.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Yang Z, Chen R, Zhang Y, Huang Y, Hong T, Sun F, et al. Scoring systems to screen for diabetic peripheral neuropathy. Cochrane Database Syst Rev. 2018;(7):CD010974. https://doi.org/10.1002/14651858.CD010974.pub2.

  59. Dros J, Wewerinke A, Bindels PJ, van Weert HC. Accuracy of monofilament testing to diagnose peripheral neuropathy: a systematic review. Ann Family Med. 2009;7:555–8.

    Article  Google Scholar 

  60. Tan LS. The clinical use of the 10g monofilament and its limitations. A review. Diab Res Clin Pract. 2010;90:1–7.

    Article  Google Scholar 

  61. Perkins BA, Olaleye D, Zinman B, Bril V. Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care. 2001;24:250–6.

    Article  CAS  PubMed  Google Scholar 

  62. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293:217–28.

    Article  CAS  PubMed  Google Scholar 

  63. Bril V, Perkins BA. Comparison of vibration perception thresholds obtained with the Neurothesiometer and the CASE IV and relationship to nerve conduction studies. Diabet Med. 2002;19:661–6.

    Article  PubMed  Google Scholar 

  64. Young MJ, Breddy JL, Veves A, Boulton AJ. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care. 1994;17:557–60.

    Article  CAS  PubMed  Google Scholar 

  65. Willits I, Cole H, Jones R, Dimmock P, Arber M, Craig J, et al. Vibra tip for testing vibration perception to detect diabetic peripheral neuropathy: a NICE medical technology guidance. Appl Health Econ Health Policy. 2015;13(4):315–24. https://doi.org/10.1007/s40258-015-0181-6.

  66. Rayman G, Vas PR, Baker N, Taylor CG Jr, Gooday C, Alder AI, et al. The Ipswich touch test: a simple and novel method to identify inpatients with diabetes at risk of foot ulceration. Diabetes Care. 2011;34:1517–8.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Madanat A, Sheshah E, Badawy EB, Abbas A, Al-Bakheet A. Utilizing the Ipswich touch test to simplify screening methods for identifying the risk of foot ulceration among diabetics: The Saudi experience. Prim Care Diabetes. 2015;9(4):304–6. https://doi.org/10.1016/j.pcd.2014.10.007.

    Article  PubMed  Google Scholar 

  68. Miller JD, Carter E, Shih J, Giovinco NA, Boulton AJ, Mills JL, et al. How to do a 3-minute diabetic foot exam. J Fam Pract. 2014;63:646–9, 653–6.

    PubMed  Google Scholar 

  69. Dyck PJ, Overland CJ, Low PA, Litchy WJ, Davies JL, Dyck PJ, et al. “Unequivocally Abnormal” vs “Usual” signs and symptoms for proficient diagnosis of diabetic polyneuropathy: Cl vs N Phys Trial. Arch Neurol. 2012;69:1609–14.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Lauria G, Hsieh ST, Johansson O, Kennedy WR, Leger JM, Mellgren SI, et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Fe-deration of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol. 2010;17:e903–49.

    Article  Google Scholar 

  71. Malik RA, Kallinikos P, Abbott CA, van Schie CH, Morgan P, Efron N, et al. Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia. 2003;46:683–8.

    Article  CAS  PubMed  Google Scholar 

  72. Tavakoli M, Quattrini C, Abbott C, Kallinikos P, Marshall A, Finnigan J, et al. Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy. Diabetes Care. 2010;33:1792–7.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Shy ME, Frohman EM, So YT, Arezzo JC, Cornblath DR, Giuliani MJ, et al. Quantitative sensory testing: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology. 2003;60:898–904.

    Google Scholar 

  74. Vas PR, Rayman G. Validation of the modified LDIFlare technique: a simple and quick method to assess C-fiber function. Muscle Nerve. 2013;47:351–6.

    Article  PubMed  Google Scholar 

  75. Tesfaye S, Boulton AJ, Dickenson AH. Mechanisms and management of diabetic painful distal symmetrical polyneuropathy. Diabetes Care. 2013;36:2456–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Spallone V, Ziegler D, Freeman R, Bernardi L, Frontoni S, Pop-Busui R, et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011;27:639–53.

    Article  PubMed  Google Scholar 

  77. Pasricha PJ. Does the emptier have no clothes? Diabetes, gastric emptying, and the syndrome of gastroparesis. Clin Gastroenterol Hepatol. 2015;13:477–9.

    Article  PubMed  Google Scholar 

  78. Ziegler D, Behler M, Schroers-Teuber M, Roden M. Near-normoglycaemia and development of neuropathy: a 24-year prospective study from diagnosis of type 1 diabetes. BMJ Open. 2015;5(6):e006559. https://doi.org/10.1136/bmjopen-2014-006559.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Callaghan BC, Little AA, Feldman EL, Hughes RA. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev. 2012;6:CD007543. https://doi.org/10.1002/14651858.CD007543.pub2.

    Article  Google Scholar 

  80. Mehra S, Tavakoli M, Kallinikos PA, Efron N, Boulton AJ, Augustine T, et al. Corneal confocal microscopy detects early nerve regeneration after pancreas transplantation in patients with type 1 diabetes. Diabetes Care. 2007;30:2608–12.

    Article  PubMed  Google Scholar 

  81. Azmi S, Ferdousi M, Petropoulos IN, Ponirakis G, Fadavi H, Tavakoli M, et al. Corneal confocal microscopy shows an improvement in small-fiber neuropathy in subjects with type 1 diabetes on continuous subcutaneous insulin infusion compared with multiple daily injection. Diabetes Care. 2015;38:e3–4.

    Article  PubMed  Google Scholar 

  82. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. 2010;376:419–30.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Oyibo SO, Prasad YDM, Jackson NJ, Jude EB, Boulton AJM. The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diab Med. 2002;19:870–3.

    Article  CAS  Google Scholar 

  85. Bril V, England J, Franklin GM, Backonja M, Cohen J, Del Toro D, et al. Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology. 2011;76:1758–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14:162–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. NICE: Neuropathic pain—pharmacological management: the pharmacological management of neuropathic pain in adults in nonspecialist settings; 2013. http://www.nice.org.uk/guidance/cg173. Accessed 20 May 2015.

  88. Tesfaye S, Wilhelm S, Lledo A, Schacht A, Tolle T, Bouhassira D, et al. Duloxetine and pregabalin: high-dose monotherapy or their combination? The “COMBO-DN study”—a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain. Pain. 2013;154:2616–25.

    Article  CAS  PubMed  Google Scholar 

  89. Gilron I, Bailey JM, Tu D, Holden RR, Jackson AC, Houlden RL. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet. 374:1252–61.

    Google Scholar 

  90. Hardy T, Sachson R, Shen S, Armbruster M, Boulton AJM. Does treatment with duloxetine for neuropathic pain impact glycemic control? Diabetes Care. 2007;30:21–6.

    Article  CAS  PubMed  Google Scholar 

  91. Taylor CP, Angelotti T, Fauman E. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res. 2007;73:137–50.

    Article  CAS  PubMed  Google Scholar 

  92. Argoff CE, Galer BS, Jensen MP, Oleka N, Gammaitoni AR. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale. Curr Med Res Opin. 2004;20(Suppl 2):S21–8.

    Article  CAS  PubMed  Google Scholar 

  93. Foster AV, Eaton C, McConville DO, Edmonds ME. Application of OpSite film: a new and effective treatment of painful diabetic neuropathy. Diabet Med. 1994;11:768–72.

    Article  CAS  PubMed  Google Scholar 

  94. Tesfaye S, Vileikyte L, Rayman G, Sindrup SH, Perkins BA, Baconja M, et al. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev. 2011;27:629–38.

    Article  CAS  PubMed  Google Scholar 

  95. Schwartz S, Etropolski MS, Shapiro DY, Rauschkolb C, Vinik AI, Lange B, et al. A pooled analysis evaluating the efficacy and tolerability of tapentadol extended release for chronic, painful diabetic peripheral neuropathy. Clin Drug Investig. 2015;35:95–108.

    Article  CAS  PubMed  Google Scholar 

  96. Javed S, Alam U, Malik RA. Treating diabetic neuropathy: present strategies and emerging solutions. Rev Diabet Stud. 2015;12:63–83.

    Article  PubMed  PubMed Central  Google Scholar 

  97. Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. 2017:1–16.

    Google Scholar 

  98. McCallum RW, Lin Z, Forster J, Roeser K, Hou Q, Sarosiek I. Gastric electrical stimulation improves outcomes of patients with gastroparesis for up to 10 years. Clin Gastroenterol Hepatol. 2011;9:314–9. e311.

    Article  PubMed  Google Scholar 

  99. Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and The Endocrine Society. Diabetes Care. 2013;36:1384–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  100. Choudhary P, Ramasamy S, Green L, Gallen G, Pender S, Brackenridge A, et al. Real-time continuous glucose monitoring significantly reduces severe hypoglycemia in hypoglycemia-unaware patients with type 1 diabetes. Diabetes Care. 2013;36:4160–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  101. Winkley K, Stahl D, Chalder T, Edmonds ME, Ismail K. Risk factors associated with adverse outcomes in a population-based prospective cohort study of people with their first diabetic foot ulcer. J Diabetes Complicat. 2007;21:341–9.

    Article  Google Scholar 

  102. Farmer KL, Li C, Dobrowsky RT. Diabetic peripheral neuropathy. Should a chaperone accompany our therapeutic approach? Pharmacol Rev. 2012;64:880–900.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Polydefkis M, Arezzo J, Nash M, Bril V, Shaibani A, Gordon RJ, et al. Safety and efficacy of ranirestat in patients with mild-to-moderate diabetic sensorimotor polyneuropathy. J Peripher Nerv Syst. 2015;20:363–71.

    Article  PubMed  Google Scholar 

  104. Ziegler D, Hanefeld M, Ruhnau KJ, Hasche H, Lobisch M, Schutte K, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-lipoic acid in diabetic neuropathy. Diabetes Care. 1999;22:1296–301.

    Article  CAS  PubMed  Google Scholar 

  105. Ziegler D, Low PA, Litchy WJ, Boulton AJ, Vinik AI, Freeman R, et al. Efficacy and safety of antioxidant treatment with alpha-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care. 2011;34:2054–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Vinik AI, Bril V, Kempler P, Litchy WJ, Tesfaye S, Price KL, et al. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial. Clin Ther. 2005;27:1164–80.

    Google Scholar 

  107. Javed S, Petropoulos IN, Alam U, Malik RA. Treatment of painful diabetic neuropathy. Ther Adv Chronic Dis. 2015;6:15–28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  108. Wahren J, Foyt H, Daniels M, Arezzo JC. Long-acting C-peptide and neuropathy in type 1 diabetes: a 12-month clinical trial. Diabetes Care. 2016;39:596–602.

    Article  CAS  PubMed  Google Scholar 

  109. American Diabetes Association. 10. Microvascular complications and foot care. Diabetes Care. 2017;40:S88–98.

    Article  Google Scholar 

  110. NICE: Diabetic foot problems: prevention and management. 2015.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diabetes and Diabetic Foot Medicine, King’s College Hospital NHS Foundation Trust, London, UK

    Prashanth R. J. Vas

  2. Neurology Department, King’s College Hospital NHS Foundation Trust, London, UK

    M. Mahdi-Rogers

Authors
  1. Prashanth R. J. Vas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Mahdi-Rogers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Prashanth R. J. Vas .

Editor information

Editors and Affiliations

  1. King’s College Hospital, London, UK

    Michael E. Edmonds

  2. School of Medicine, Yale University, New Haven, CT, USA

    Bauer E. Sumpio

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Vas, P.R.J., Mahdi-Rogers, M. (2019). Diabetic Neuropathy. In: Edmonds, M., Sumpio, B. (eds) Limb Salvage of the Diabetic Foot. Springer, Cham. https://doi.org/10.1007/978-3-319-17918-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-17918-6_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-17917-9

  • Online ISBN: 978-3-319-17918-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation